Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
Sergio E. Baranzini(University of California, San Francisco), Jorge R. Oksenberg(University of California, San Francisco), Michaela F. George(University of California, San Francisco), Ari Green(University of California, San Francisco), Bernard M.J. Uitdehaag(Amsterdam UMC Location Vrije Universiteit Amsterdam), Robin Lincoln(University of California, San Francisco), Yvonne Naegelin(University Hospital of Basel), Achim Gass(Heidelberg University), Bruce Cree(University of California, San Francisco), Douglas S. Goodin(San Francisco VA Medical Center), Darin T. Okuda(The University of Texas Southwestern Medical Center), Jeroen J.G. Geurts(Amsterdam Neuroscience), Rab K. Prinjha(GlaxoSmithKline (United States)), Emmanuelle Waubant(University of California, San Francisco), Hourieh Mousavi(University of California, San Francisco), Ludwig Kappos(Novartis (Switzerland)), Jill Richardson(GlaxoSmithKline (United Kingdom)), Rosa Guerrero(University of California, San Francisco), Frederik Barkhof(Netherlands Institute for Neuroscience), Rachel A. Gibson(GlaxoSmithKline (United Kingdom)), Paul M. Matthews(John Radcliffe Hospital), Pamela Qualley(University of California, San Francisco), Hugo Vrenken(Amsterdam Neuroscience), Stacy J. Caillier(University of California, San Francisco), Raija L.P. Lindberg, Leslie Hall(GlaxoSmithKline (United Kingdom)), Refujia Gomez(University of California, San Francisco), Joanne Wang, Michael R. Johnson(Imperial College London), Stephen L. Hauser(University of California, San Francisco), Daniel Pelletier(University of California, San Francisco), Ernst-Wilhelm Radüe(Düsseldorf University Hospital), Chris H. Polman(Vrije Universiteit Amsterdam), Madeleine H Sombekke(Vrije Universiteit Amsterdam), Aspasia Angelakopoulou(GlaxoSmithKline (United Kingdom)), Jolijn J Kragt, N. W. Galwey(GlaxoSmithKline (United Kingdom))
Cited by 479
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data
|NeuroImage|2006|6.6k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k